AAVLP amyloid beta vaccine - 2A Pharma
Alternative Names: 2AP-04; AAVLP-Amyloid-β vaccine; Anti-amyloid-beta vaccine candidate - 2A PharmaLatest Information Update: 28 Jun 2023
At a glance
- Originator 2A Pharma
- Class Alzheimer vaccines; Peptide vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for preclinical development in Alzheimer's-disease in Sweden (Parenteral)
- 15 May 2019 Preclinical trials in Alzheimer's disease in Sweden (Parenteral) (2A Pharma pipeline, May 2019)